Guam Behavioral Health & Wellness Center

Guam Behavioral Health & Wellness Center, a U.S. government entity (territory agency) based in Tamuning, Guam, operates as a federal grant recipient and prime contract awardee delivering community mental health services, substance abuse treatment, crisis intervention, and tobacco regulatory compliance work to civilian federal agencies. GBHWC is Guam's sole state mental health authority and receives no set-aside designations, competing on full-and-open basis as a government entity.

GBHWC's federal footprint is dominated by grant work from the Department of Health and Human Services, particularly the Substance Abuse and Mental Health Services Administration (SAMHSA), which accounts for the vast majority of its award volume. On the contract side, the Food and Drug Administration awarded GBHWC a single-award Indefinite Delivery/Indefinite Quantity contract (ceiling $3.028 million, ultimate completion September 2029) for tobacco retail inspection and compliance enforcement across Guam and other U.S. territories. The work includes recruiting underage purchasers, conducting undercover inspections, and submitting results to enforce federal tobacco regulations under Time and Materials pricing. This FDA contract represents GBHWC's only material contract ceiling value and builds on prior tobacco compliance work with FDA dating to 2019.

GBHWC's grant portfolio spans crisis and mental health services. Recent major grants include $735 thousand (CFDA 93.532, awarded September 2026) to expand the Guam Focus on Life youth suicide prevention and crisis intervention program serving youth to age 24; $525 thousand (CFDA 93.490, September 2026) to sustain the Center of Hope, Guam's only residential substance use disorder treatment for pregnant and postpartum women and their children; $250 thousand (CFDA 93.00R, September 2026) for the Guam 988 Lifeline Center Follow-Up project providing 24/7 crisis support via call, chat, and text; and $1.559712 million (CFDA 93.958, October 2025) in Block Grants for Community Mental Health Services to support comprehensive community mental health services for adults with serious mental illness and children with serious emotional disturbance. Earlier grants funded the Guam Opioid Response Project (substance use prevention and treatment), Projects for Assistance in Transition from Homelessness (PATH), evidence-based prevention capacity expansion, System of Care expansion for children and youth, and mental health awareness trainings (Project Tiningo). Grant work is performed in Guam, with all assistance types including project grants, formula grants, and block grants.

GBHWC serves eight distinct federal customer agencies. SAMHSA dominates by award count (61 awards across three listed lines in the top-customers block), followed by the Department of Justice Office of Justice Programs Bureau of Justice Assistance (11 awards) and FDA (6 awards carrying $5.8 million combined potential value, representing 100% of combined potential value across the full portfolio). The concentration is marked: while GBHWC reports 86 total prime and sub awards, combined potential value sits at $5.8 million against $152.8 million obligated across all awards — a ratio reflecting heavy formula-grant and block-grant obligations that dwarf the contract ceiling. Award volume has grown from seven in 2022 to twelve in 2025, with six awarded year-to-date in 2026.

As a prime, GBHWC holds 69 awards (80%); as a sub-recipient or subcontractor, it holds 17 awards (20%). Subcontract work routes through the National Association of State Mental Health Program Directors (technical assistance on coalition and transformation initiatives) and grant sub-awards flow through the Government of Guam Department of Administration, the Superior Court of Guam, and other territorial agencies to deliver forensic medical examination services for sexual assault, residential substance abuse treatment for state prisoners, peer recovery support, child and adolescent services (including autism programs and mobile crisis response), and juvenile justice programs. Ten awards complete within the next twenty-four months, triggering recompete exposure on those grants and the FDA contract.